FSSAI Bans Noble Healthcare’s Venolex Forte and Halts Tripura Water Licence
In a sweeping enforcement action on August 3, the Food Safety and Standards Authority of India revoked the licence of Mater Drinking Water, a Tripura‑based drinking‑water supplier, and ordered an immediate ban on Venolex Forte, a health‑supplement product from Noble Healthcare in Mohali, Punjab.
The regulator posted the announcement on its X platform, stating that both entities were found to be in “gross violation of food‑safety norms.” FSSAI reiterated that consumer protection will drive ongoing surveillance and punitive measures in the food and nutraceutical sectors.
Citing Section 36(3)(b) of the Food Safety and Standards Act, 2006, the authority stopped all production, storage, distribution and retail of Venolex Forte. Testing uncovered prohibited substances such as calcium dibasic, diosmin and uforbia prostret, which do not appear in the approved list of ingredients under the 2022 Health Supplements and Novel Food regulations.
The supplement also contained 90 mg of vitamin C per dose, a level that surpasses the Recommended Dietary Allowance recommended by the ICMR‑NIN 2020 guidelines. Moreover, the product was advertised as a “dietary food supplement” and displayed the FSSAI licence number prominently, creating a false impression of regulatory approval.
FSSAI pointed out that the misleading labelling could misguide consumers regarding the product’s compliance status. The early investigation concluded that Venolex Forte was not in line with the Food Safety and Standards Act, prompting the swift ban.
The authority assures the public that it will continue to enforce stringent standards to safeguard health and will not tolerate any breach of food‑safety laws.